Real-world disproportionality analysis of cardiac failure associated with novel antineoplastic agents in breast cancer: a pharmacovigilance study. [PDF]
Li H, Wu Y, Guo Q, Guo C, Liu F, Huo L.
europepmc +1 more source
Safety assessment of obinutuzumab: Real-world adverse event analysis based on the FAERS and JADER databases from 2013 to 2025. [PDF]
Li X, Liang H, Leng P, Cao Z.
europepmc +1 more source
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) Codes. [PDF]
Parry RE +5 more
europepmc +1 more source
Symptoms Associated With Gadolinium Exposure: Different Patterns and Rates Between Linear and Macrocyclic Gadolinium-Based Contrast Agents. [PDF]
Shahid I, Lancelot E.
europepmc +1 more source
Real-world study of adverse events associated with sodium zirconium cyclosilicate based on FDA adverse event reporting system and VigiAccess database. [PDF]
Jia X, Liu L, Wang P.
europepmc +1 more source
A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions [PDF]
core +1 more source
Postmarketing analysis of sotatercept: identifying serious unlabelled events. [PDF]
Cao Z, Xiao Q, Li X, Zhang H, Zhang M.
europepmc +1 more source
Drug-induced insulin autoimmune syndrome: a clinico-epidemiological analysis integrating pharmacovigilance data and case series. [PDF]
Yu X +6 more
europepmc +1 more source
Comprehensive analysis of metformin-associated lactic acidosis: Insights from the FDA Adverse Event Reporting System (FAERS). [PDF]
Jin J, Ge W, Yu A, Lan Z, Zhang S.
europepmc +1 more source

